MEMORIAL HOSPITAL WEST
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.6M
- Transactions
- 478
- Companies
- 40
- Average per transaction
- $3,381
Who reported the payments
| Astellas Pharma Global Development | $445,392 |
| Genmab A/s | $430,687 |
| Microvention, Inc. | $158,328 |
| Tesaro, Inc. | $68,918 |
| Stryker | $63,216 |
| Novartis | $50,875 |
| Janssen Research & Development, LLC | $33,700 |
| E.r. Squibb & Sons, L.L.C. | $33,691 |
| Merck | $33,315 |
| Regeneron | $30,623 |
| Shockwave Medical, Inc | $27,200 |
| Daiichi Sankyo Inc. | $23,505 |
| Janssen Scientific Affairs, LLC | $22,000 |
| AstraZeneca | $17,690 |
| Seagen Inc. | $16,000 |
| Sanofi | $12,300 |
| Genmab U.S., Inc. | $12,000 |
| Incyte Corporation | $11,814 |
| Philips North America LLC | $11,365 |
| Genentech, Inc. | $10,000 |
| M.a. Med Alliance S.A. | $9,120 |
| Takeda Pharmaceuticals U.S.A., Inc. | $7,500 |
| Jazz Pharmaceuticals Inc. | $7,000 |
| Zimmer Biomet | $6,956 |
| Regeneron Healthcare Solutions, Inc. | $6,500 |
| Astellas Pharma US Inc | $6,000 |
| BTG International Inc. | $5,800 |
| Johnson & Johnson | $5,500 |
| Azurity Pharmaceuticals, Inc. | $5,397 |
| Penumbra, Inc. | $5,150 |
| Exelixis Inc. | $5,000 |
| AbbVie | $4,000 |
| Kyowa Kirin, Inc. | $4,000 |
| Bayer | $3,500 |
| Novocure Inc. | $3,500 |
| Sanofi US Services Inc. | $3,465 |
| Sterilmed, Inc. | $2,202 |
| AMAG Pharmaceuticals, Inc. | $2,200 |
| Hoffmann-la Roche Limited | $2,100 |
| Alnylam Pharmaceuticals Inc. | $2,000 |